Genestra – super lipoic acid® new improved – 60 vcaps Fashion

Description
.cs2A2EDA5D{text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;line-height:1.3;background-color:#FFFFFF}
.cs4560F57D{color:#7C7A81;background-color:#FFFFFF;font-family: Microsoft Sans Serif ;font-size:12pt;font-weight:bold;font-style:normal;}
.cs6AC4D59F{color:#7C7A81;background-color:#FFFFFF;font-family: Microsoft Sans Serif ;font-size:12pt;font-weight:normal;font-style:normal;}
.csC784464D{color:#7C7A81;background-color:#FFFFFF;font-family: Microsoft Sans Serif ;font-size:9pt;font-weight:normal;font-style:normal;}
.csC639CDFA{text-align:left;text-indent:0pt;margin:0pt 0pt 12pt 0pt;line-height:1.3;background-color:#FFFFFF}
.cs9D26C486{color:#7C7A81;background-color:#FFFFFF;font-family: Microsoft Sans Serif ;font-size:7.5pt;font-weight:normal;font-style:normal;}
Alpha lipoic acid formula
• Provides antioxidant support for maintenance of good health
• Includes 700 mg of alpha-lipoic acid per daily serving
An estimated 30-50% of patients with Type II diabetes experience neuropathy symptoms.1 Hyperglycemia, impaired insulin signaling and increased oxidative stress are each considered major contributing factors for neuropathy symptoms in diabetic patients.1 Alpha-lipoic acid is a naturally occurring fatty acid that is a cofactor in cellular energy metabolism processes, acts as an antioxidant and promotes glucose cellular intake. In diabetic patients with Distal Symmetric Polyneuropathy (DSP), daily supplementation with 600 mg of alpha-lipoic acid for 5 weeks significantly decreased stabbing; burning pains, and improved Neuropathy Symptoms and Change (NSC) scores.2
REFERENCES
1. Callaghan BC et al. Lancet Neurol. 2012; 11(6): 521-534.
2. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R. Diabetes Care. 2006; 29(11): 2365-2370.
Additional Information
Title | Default Title |
---|